Free Trial

T-Notes Trim Initial Uptick

BOND SUMMARY

T-Notes have ebbed off the session high at 139-20 printed just after the re-open in reaction to the news that the promising AstraZeneca/Oxford University phase 3 trial of a Covid-19 vaccine has been put to a halt after the detection of an unexplained illness in one participant. Broader unwinding of initial risk-off flows has applied some pressure to T-Notes, dragging them back into yesterday's range. The contract deals +0-03+ at 139-16 at typing. Cash Tsy curve has bull flattened, yields sit 0.2-1.7bp lower at typing. Eurodollar futures trade unch. to +0.5 tick through the reds.

  • JGB futures have wavered, sticking to a fairly tight range, and last trade +10 at 151.94. Curve runs flatter in cash trade. Flash machine tool orders and 6-Month Bill supply figure on Japan's docket today.
  • In Australia, YM +0.5 & XM +6.5. Bull flattening evident also in cash ACGB space, with yields sitting 0.2-7.7bp lower as they play catch-up with overnight moves in Tsys. Bills last seen unch. to -1 tick through the reds. The RBA offered to buy A$2.0 worth of ACGBs (eligible maturities: Apr '23 & Apr '24). Little market reaction to a jump in Westpac Consumer Confidence (93.8 vs. prev. 79.5). Focus moves to Australian housing finance data and Chinese inflation figures, due shortly.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.